Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barbra Johnson
Contact Barbra Johnson, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
The therapeutic gene editing solution - cell therapy for solid tumors
Engineered immune cell therapy has revolutionised the field of cancer therapeutics. However, the success observed against haematological malignancies has not translated well to the more complex and refractory solid tumour environment. This webinar will explore the reasons that underlie this and discuss the innovative strategies and gene editing technologies that are being employed to overcome these limitations.
Direct control of CAR T cells through small molecule-regulated antibodies
Abstract Antibody-based therapeutics have experienced a rapid growth in recent years and are now utilized in various modalities spanning from conventional antibodies, antibody-drug conjugates, bispecific antibodies to chimeric antigen receptor (CAR) T cells. Many next generation antibody therapeutics achieve enhanced potency but often increase the risk of adverse events.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barbra Johnson
Contact Barbra Johnson, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack